Financhill
Sell
17

NHTC Quote, Financials, Valuation and Earnings

Last price:
$4.44
Seasonality move :
14.44%
Day range:
$4.16 - $4.48
52-week range:
$4.02 - $7.40
Dividend yield:
18.1%
P/E ratio:
60.51x
P/S ratio:
1.18x
P/B ratio:
1.44x
Volume:
22.7K
Avg. volume:
32.9K
1-year change:
-22.05%
Market cap:
$50.9M
Revenue:
$43.9M
EPS (TTM):
$0.07
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $77.6M $62.1M $60M $49.1M $43.9M
Revenue Growth (YoY) -59.56% -20.03% -3.33% -18.12% -10.6%
 
Cost of Revenues $20.1M $17M $15M $12.7M $11.2M
Gross Profit $57.5M $45.1M $45M $36.5M $32.7M
Gross Profit Margin 74.1% 72.63% 74.99% 74.23% 74.56%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $62.8M $44.4M $43.4M $36.7M $34.4M
Other Inc / (Exp) -$338K $821K -$61K $872K $2.4M
Operating Expenses $62.8M $44.4M $43.4M $36.7M $34.4M
Operating Income -$5.3M $669K $1.6M -$270K -$1.7M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -$5.6M $1.5M $1.5M $602K $745K
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $14K $647K $425K $289K $177K
Net Income to Company -$5.6M $843K $1.1M $313K $568K
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$5.6M $843K $1.1M $313K $568K
 
Basic EPS (Cont. Ops) -$0.52 $0.08 $0.10 $0.03 $0.05
Diluted EPS (Cont. Ops) -$0.52 $0.07 $0.09 $0.03 $0.05
Weighted Average Basic Share $10.9M $10.6M $11M $11.4M $11.4M
Weighted Average Diluted Share $10.9M $11.4M $11.4M $11.4M $11.5M
 
EBITDA -$4.9M $1.1M $1.9M -$66K -$1.5M
EBIT -$5.3M $669K $1.6M -$270K -$1.7M
 
Revenue (Reported) $77.6M $62.1M $60M $49.1M $43.9M
Operating Income (Reported) -$5.3M $669K $1.6M -$270K -$1.7M
Operating Income (Adjusted) -$5.3M $669K $1.6M -$270K -$1.7M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $14.1M $14.3M $11.7M $10.6M $10.7M
Revenue Growth (YoY) -17.03% 1.08% -17.93% -9.4% 0.72%
 
Cost of Revenues $3.6M $3.7M $3.1M $2.7M $2.8M
Gross Profit $10.5M $10.6M $8.6M $7.9M $7.9M
Gross Profit Margin 74.26% 74.31% 73.56% 74.67% 74.14%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $9.8M $10.1M $8.8M $8.2M $8.2M
Other Inc / (Exp) $385K -$53K $187K $585K $441K
Operating Expenses $9.8M $10.1M $8.8M $8.2M $8.2M
Operating Income $668K $479K -$145K -$292K -$275K
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items $1.1M $426K $42K $293K $166K
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $418K -$45K -$5K $121K $131K
Net Income to Company $635K $471K $47K $172K $35K
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $635K $471K $47K $172K $35K
 
Basic EPS (Cont. Ops) $0.06 $0.04 $0.00 $0.02 $0.00
Diluted EPS (Cont. Ops) $0.06 $0.04 $0.00 $0.02 $0.00
Weighted Average Basic Share $10.7M $11.1M $11.4M $11.4M $11.5M
Weighted Average Diluted Share $11.4M $11.4M $11.4M $11.5M $11.5M
 
EBITDA $767K $560K -$95K -$253K -$244K
EBIT $668K $479K -$145K -$292K -$275K
 
Revenue (Reported) $14.1M $14.3M $11.7M $10.6M $10.7M
Operating Income (Reported) $668K $479K -$145K -$292K -$275K
Operating Income (Adjusted) $668K $479K -$145K -$292K -$275K
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $63.3M $60.5M $52.7M $45.5M $43.1M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $18.1M $14.9M $13.6M $11.6M $11.2M
Gross Profit $45.2M $45.6M $39.2M $33.9M $31.9M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $47.3M $43.3M $39M $35.2M $33M
Other Inc / (Exp) -$863K $126K $503K $2.1M $2.2M
Operating Expenses $47.3M $43.3M $39M $35.2M $33M
Operating Income -$2.1M $2.4M $174K -$1.4M -$1.1M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -$2.9M $2.5M $677K $722K $1.1M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$196K $876K $320K $324K $357K
Net Income to Company -$2.7M $1.6M $357K $398K $754K
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$2.7M $1.6M $357K $398K $754K
 
Basic EPS (Cont. Ops) -$0.26 $0.14 $0.03 $0.04 $0.07
Diluted EPS (Cont. Ops) -$0.26 $0.14 $0.03 $0.04 $0.07
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -$1.7M $2.7M $392K -$1.2M -$986K
EBIT -$2.1M $2.4M $174K -$1.4M -$1.1M
 
Revenue (Reported) $63.3M $60.5M $52.7M $45.5M $43.1M
Operating Income (Reported) -$2.1M $2.4M $174K -$1.4M -$1.1M
Operating Income (Adjusted) -$2.1M $2.4M $174K -$1.4M -$1.1M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $45.5M $43.9M $36.6M $33M $32.1M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $13M $10.9M $9.4M $8.4M $8.4M
Gross Profit $32.5M $33M $27.2M $24.6M $23.7M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $33.1M $32M $27.5M $26M $24.6M
Other Inc / (Exp) $603K -$92K $472K $1.7M $1.5M
Operating Expenses $33.1M $32M $27.5M $26M $24.6M
Operating Income -$597K $1.1M -$313K -$1.4M -$878K
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items $6K $992K $159K $279K $645K
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$90K $139K $34K $69K $249K
Net Income to Company $96K $853K $125K $210K $396K
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $96K $853K $125K $210K $396K
 
Basic EPS (Cont. Ops) $0.01 $0.07 $0.01 $0.02 $0.04
Diluted EPS (Cont. Ops) $0.01 $0.07 $0.01 $0.02 $0.04
Weighted Average Basic Share $31.7M $32.9M $34M $34.3M $34.4M
Weighted Average Diluted Share $33.3M $34.3M $34.1M $34.3M $34.4M
 
EBITDA -$296K $1.3M -$157K -$1.3M -$778K
EBIT -$597K $1.1M -$313K -$1.4M -$878K
 
Revenue (Reported) $45.5M $43.9M $36.6M $33M $32.1M
Operating Income (Reported) -$597K $1.1M -$313K -$1.4M -$878K
Operating Income (Adjusted) -$597K $1.1M -$313K -$1.4M -$878K
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $96M $92.4M $83.8M $69.7M $56.2M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net -- -- -- -- --
Inventory $6.4M $3.8M $5.3M $4.5M $4.3M
Prepaid Expenses -- -- -- -- --
Other Current Assets $5.9M $3.6M $4.4M $3.4M $3.8M
Total Current Assets $108.4M $99.7M $93.5M $77.6M $64.2M
 
Property Plant And Equipment $3.9M $4.3M $3.5M $4.4M $3.6M
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets $4.2M $1.2M $1.1M $685K $908K
Total Assets $118.5M $105.9M $98.4M $82.8M $69.1M
 
Accounts Payable $680K $580K $761K $810K $990K
Accrued Expenses $3.7M $4.1M $4.4M $3.3M $2.5M
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations $1.7M $1.2M $1.2M $1.1M $1.1M
Other Current Liabilities $14M $9.8M $7.2M $5.8M $4.7M
Total Current Liabilities $26.3M $21.5M $24.7M $20.4M $20M
 
Long-Term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities $43.4M $38.2M $38.9M $32.7M $27.5M
 
Common Stock $13K $13K $13K $13K $13K
Other Common Equity Adj -$1.3M -$336K -$492K -$1M -$1.1M
Common Equity $75.1M $67.7M $59.5M $50.2M $41.6M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $75.1M $67.7M $59.5M $50.2M $41.6M
 
Total Liabilities and Equity $118.5M $105.9M $98.4M $82.8M $69.1M
Cash and Short Terms $96M $92.4M $83.8M $69.7M $56.2M
Total Debt -- -- -- -- --
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $90.8M $84.6M $70.7M $58.4M $22.9M
Short Term Investments -- -- -- -- $23.4M
Accounts Receivable, Net -- -- -- -- --
Inventory $4.3M $4.4M $5M $4.9M $3.7M
Prepaid Expenses -- -- -- -- --
Other Current Assets $5M $4.4M $3.4M $3.7M $3.8M
Total Current Assets $100M $93.4M $79M $67M $53.8M
 
Property Plant And Equipment $4.8M $3.8M $4.7M $3.8M $3M
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets $1.2M $1.1M $622K $716K $1.2M
Total Assets $107.1M $99M $84.6M $71.8M $58.3M
 
Accounts Payable $887K $879K $983K $666K $548K
Accrued Expenses $4.8M $4.2M $3M $3M $2.7M
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations $1.2M $1.3M $1.2M $1.2M $1.2M
Other Current Liabilities $10.9M $7.6M $6M $4.9M $4.1M
Total Current Liabilities $21.3M $22.9M $20.2M $20.8M $21.1M
 
Long-Term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities $38.4M $37.4M $32.7M $28.5M $23M
 
Common Stock $13K $13K $13K $13K $13K
Other Common Equity Adj -$893K -$476K -$1.3M -$1.3M -$960K
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $68.7M $61.6M $51.9M $43.3M $35.3M
 
Total Liabilities and Equity $107.1M $99M $84.6M $71.8M $58.3M
Cash and Short Terms $90.8M $84.6M $70.7M $58.4M $46.3M
Total Debt -- -- -- -- --
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders -$5.6M $843K $1.1M $313K $568K
Depreciation & Amoritzation $387K $410K $299K $204K $164K
Stock-Based Compensation -- -- -- -- $161K
Change in Accounts Receivable -- -- -- -- --
Change in Inventories $5.8M $2.7M -$1.5M $680K $228K
Cash From Operations -$18.6M $1.9M $1M -$4.9M -$4.3M
 
Capital Expenditures $189K $211K $225K $143K $46K
Cash Acquisitions -- -- -- -- --
Cash From Investing -$189K -$211K -$225K -$143K -$46K
 
Dividends Paid (Ex Special Dividend) -$7.3M -$9.1M -$9.1M -$9.1M -$9.2M
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -$10.1M -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -$17.5M -$9.1M -$9.1M -$9.1M -$9.2M
 
Beginning Cash (CF) $135.7M $99.4M $92.9M $84.4M $69.7M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$36.3M -$7.5M -$8.3M -$14.1M -$13.5M
Ending Cash (CF) $99.4M $92.9M $84.4M $69.7M $56.2M
 
Levered Free Cash Flow -$18.8M $1.7M $791K -$5M -$4.3M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $635K $471K $47K $172K $35K
Depreciation & Amoritzation $99K $81K $50K $39K $31K
Stock-Based Compensation -- -- -- $38K $34K
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -$121K -$728K $133K -$192K $613K
Cash From Operations -$512K -$1.1M -$2.3M -$869K -$436K
 
Capital Expenditures $79K $18K $52K $18K $7K
Cash Acquisitions -- -- -- -- --
Cash From Investing -$79K -$18K -$52K -$18K $9.8M
 
Dividends Paid (Ex Special Dividend) -$2.3M -$2.3M -$2.3M -$2.3M -$2.3M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -$2.3M -$2.3M -$2.3M -$2.3M -$2.3M
 
Beginning Cash (CF) $93.7M $88.6M $75.7M $61.6M $15.6M
Foreign Exchange Rate Adjustment $463K -$65K -$352K $34K $266K
Additions / Reductions -$2.9M -$3.4M -$4.6M -$3.2M $7.1M
Ending Cash (CF) $91.3M $85.2M $70.7M $58.4M $22.9M
 
Levered Free Cash Flow -$591K -$1.1M -$2.3M -$887K -$443K
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$2.7M $1.6M $357K $398K $754K
Depreciation & Amoritzation $398K $346K $218K $178K $134K
Stock-Based Compensation -- -- -- $123K $147K
Change in Accounts Receivable -- -- -- -- --
Change in Inventories $3.9M -$168K -$732K $120K $1.3M
Cash From Operations -$1.4M $2.9M -$4.2M -$3.3M -$3.5M
 
Capital Expenditures $155K $229K $190K $45K $51K
Cash Acquisitions -- -- -- -- --
Cash From Investing -$155K -$229K -$190K -$45K -$23.1M
 
Dividends Paid (Ex Special Dividend) -$11.5M -$9.1M -$9.1M -$9.2M -$9.2M
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -$12M -$9.1M -$9.1M -$9.2M -$9.2M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$13.6M -$6.5M -$13.5M -$12.5M -$35.8M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -$1.6M $2.6M -$4.4M -$3.3M -$3.6M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $96K $853K $125K $210K $396K
Depreciation & Amoritzation $301K $237K $156K $130K $100K
Stock-Based Compensation -- -- -- $123K $109K
Change in Accounts Receivable -- -- -- -- --
Change in Inventories $2.2M -$675K $140K -$420K $619K
Cash From Operations -$1.5M -$557K -$5.8M -$4.2M -$3.5M
 
Capital Expenditures $147K $165K $130K $32K $37K
Cash Acquisitions -- -- -- -- --
Cash From Investing -$147K -$165K -$130K -$32K -$23.1M
 
Dividends Paid (Ex Special Dividend) -$6.9M -$6.9M -$6.9M -$6.9M -$6.9M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -$6.9M -$6.9M -$6.9M -$6.9M -$6.9M
 
Beginning Cash (CF) $289M $272.3M $239.5M $198M $97.7M
Foreign Exchange Rate Adjustment $413K -$151K -$858K -$145K $174K
Additions / Reductions -$8.5M -$7.6M -$12.8M -$11.2M -$33.5M
Ending Cash (CF) $280.9M $264.5M $225.9M $186.7M $64.4M
 
Levered Free Cash Flow -$1.7M -$722K -$5.9M -$4.2M -$3.5M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock